WCIO 2021 | Dalian, China

Scientific Program

Opening Ceremony & Keynote Forum

Opening Ceremony

Time: 09:00-09:15, Sept. 25, 2021

Plenary Forum Time: 09:15-12:00, Sept. 25, 2021
Moderator	TBD
Time	Speeches and Speakers
09:15-09:20	Moderator’s Introduction
09:20-09:45	Title: R&D of Broad-spectral Antivirals Dr. Shibo Jiang, Director, Institute of Medical Microbiology, Fudan University, China
09:45-10:10	Title: Drug Research Based on Protein-protein Interaction Dr. Qidong You, Professor & Dean, School of Pharmacy, China Pharmaceutical University, China
10:10-10:35	Title: The Application of Prodrug Technology in the Discovery of New Drugs with Enhancement Dr. Qun (Max) Dang, President, Genuine Biotech, China
10:35-11:00	Title: Cell Therapy for Kras-driven Cancer Dr. Yi Jin, CSO, Shanghai Genechem Co.,Ltd., China
11:00-11:25	Sponsor Title: TBD Dr. Yongcong Tan, Senior Director, Sanyou Biopharmaceuticals Co., Ltd., China
11:25-12:00	High-level dialogue Chair: Dr. Xinhua Zhou, CEO, Genor Biopharma Co. Ltd, China

Battlefield 1: Philosophy of Immuno-Oncology Time: Afternoon, Sept. 25, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available
14:00-14:25	Title: Endogenous Galectin-1 in T Lymphocytes Regulates Anti-Prostate Cancer Immunity Dr. Diego Laderach, Head of Molecular and Functional Glyco-Oncology Lab Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales de la Universidad de Buenos Aires, Argentina
14:25-14:50	Title: Positive Role of Chinese Herbal Medicine in Cancer Immune Regulation Dr. Sumei Wang, Associate Professor, Department of Oncology, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical, China
14:50-15:15	Title: The Mechanisms of Action of Plasmodium Immunotherapy for Cancer Dr. Xiaoping Chen, Professor, Guangzhou Institutes of Biomedicine and Health Chinese Academy of Sciences, China
15:15-15:30	Coffee Break
15:30-15:55	Speech Opportunity Available
15:55-16:20	Speech Opportunity Available
16:20-16:45	Speech Opportunity Available
16:45-17:10	Speech Opportunity Available

Battlefield 2: Global Immuno-Oncology Landscape Analysis Update Time: Afternoon, Sept. 25, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: circHIPK3 promotes oxaliplatin-resistance in colorectal cancer via autophagy Dr. Xin Zhang, Deputy Director, Qilu Hospital of Shandong University China
14:00-14:25	Title??COX-2 Expression and on Circulating Tumor Cells Predict Worse Survival in Patients with Nasopharyngeal Carcinoma: A Prospective Analysis Dr. Feng Wang, Department of Oncology, West China Hospital, Sichuan University, Chengdu, PR China
14:25-14:50	Title: TBD Dr. Weijie Li, Department of Pathology and Laboratory Medicine, Children’s Mercy Hospital, University of Missouri-Kansas City School of Medicine, USA
14:50-15:15	Speech Opportunity Available
15:15-15:30	Coffee Break

Battlefield 3: Emerging IO Biomarkers Time: Afternoon, Sept. 25, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available
14:00-14:25	Title: TBD Dr. Luo Yu, Associate Professor, Shanghai University of Engineering Sciecne , China
14:25-14:50	Speech Opportunity Available
14:50-15:15	Speech Opportunity Available
15:15-15:30	Coffee Break

Battlefield 4: Adoptive Cell Therapy Time: Afternoon, Sept. 25, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Title: Protein and Signaling Pathway Responses to rhIL-6 Intervention before Lobaplatin Treatment in Human Osteosarcoma Dr. Qiong Ma, Tangdu Hospital, Fourth Military Medical University, Xi’an, China
14:00-14:25	Title: TBD Dr. AC Matin, Stanford University, USA
14:25-14:50	Title: Suppression of Cancer by Inhition of NF-kappa B in Peritoneal Cells Dr. Kazuo Umezawa, Aichi Medical University, Japan
14:50-15:15	Title: TBD Dr. Qingling Zhang, Department of Pathology, School of Basic Medical Sciences,Southern Medical University,Guangzhou,China
15:15-15:30	Coffee Break
15:30-15:55	Speech Opportunity Available
15:55-16:20	Speech Opportunity Available
16:20-16:45	Speech Opportunity Available
16:45-17:10	Title: TBD Mojtaba Fathi, Cancer Gene Therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran

Battlefield 5: Customized Cancer Vaccines Time: Morning, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Title: The Role of PADI2 in Endometrial Carcinogenesis Dr. Zhou Q, State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China
09:25-09:50	Title: Cadmium-induced Oxidative Stress and Immunosuppression Mediated Mitochondrial Apoptosis via JNK-FoxO3a-PUMA pathway in Common Carp (Cyprinus carpio L.) Gills Dr. Xiaohua Teng, College of Animal Science and Technology, Northeast Agricultural University, Harbin, , PR China
09:50-10:15	Title: TBD Dr. Xinjun Wang, Department of Neurosurgery, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China
10:15-10:30	Coffee Break

Battlefield 6: Disruptive OI Technologies Time: Morning, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Speech Opportunity Available
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

Battlefield 7: Engineering and Bioanalysis in IO Time: Morning, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Title: TBD Dr. Bing Cheng Lin, Department of Biotechnology, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian , China
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

Battlefield 8: Rational Combinational Cancer Immunotherapy Time: Morning, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Title: TBD Dr. Qinghua Zhou, Lung Cancer Center/Lung Cancer Institute, West China Hospital, Sichuan University, Chengdu, China
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

Battlefield 9: Antibody as Cancer Immunotherapy Time: Afternoon, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available
14:00-14:25	Title: TBD Dr. Jianqiang Li, Hebei Senlang Biotechnology Co., Ltd., Shijiazhuang, Hebei, China
14:25-14:50	Speech Opportunity Available
14:50-15:15	Speech Opportunity Available
15:15-15:30	Coffee Break

Battlefield 10: Immunomodulatory Proteins and Polysaccharides Time: Afternoon, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available
14:00-14:25	Speech Opportunity Available
14:25-14:50	Speech Opportunity Available
14:50-15:15	Speech Opportunity Available
15:15-15:30	Coffee Break

Battlefield 11: Translational Immuno-Oncology and Clinical Practices Time: Afternoon, Sept. 26, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
13:30-13:35	Chair’s Introduction
13:35-14:00	Speech Opportunity Available
14:00-14:25	Speech Opportunity Available
14:25-14:50	Speech Opportunity Available
14:50-15:15	Speech Opportunity Available
15:15-15:30	Coffee Break

Battlefield 12: Oncolytic Virus Immuno-Oncology Time: Morning, Sept. 27, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Speech Opportunity Available
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

Battlefield 13: Microbiome Enhanced Cancer Immunotherapy Time: Morning, Sept. 27, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Speech Opportunity Available
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

Battlefield 14: Emerging Immuno-Oncology Targets Time: Morning, Sept. 27, 2021
Chair	Call for Chair
Co-chair	Call for Co-chair
Time	Speeches and Speakers
08:30-08:35	Chair’s Introduction
08:35-09:00	Speech Opportunity Available
09:00-09:25	Speech Opportunity Available
09:25-09:50	Speech Opportunity Available
09:50-10:15	Speech Opportunity Available
10:15-10:30	Coffee Break

©2018-2021 All rights reserved by BIT Congress Inc.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629